Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

The safety of systemic treatments that can be used for geriatric psoriasis patients: a review.

Wong JW, Koo JY.

Dermatol Res Pract. 2012;2012:367475. doi: 10.1155/2012/367475. Epub 2012 May 28.

2.

Etanercept and efalizumab for the treatment of psoriasis: a systematic review.

Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. Review.

3.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
4.

Adverse events from systemic therapies for psoriasis are common in clinical practice.

Pearce DJ, Higgins KB, Stealey KH, Balkrishnan R, Crane MM, Camacho F, Fleischer AB Jr, Feldman SR.

J Dermatolog Treat. 2006;17(5):288-93.

PMID:
17092859
5.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
6.

To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.

Huang W, Cordoro KM, Taylor SL, Feldman SR.

J Am Acad Dermatol. 2008 Jun;58(6):970-7. doi: 10.1016/j.jaad.2008.03.004. Epub 2008 Apr 2. Review.

PMID:
18384909
7.

[Treatment of psoriasis with biologics: a survey of dermatological and rheumatological practice at Reims University Hospital].

Adnot-Desanlis L, Brochot P, Eschard JP, Bernard P, Reguiaï Z.

Ann Dermatol Venereol. 2012 May;139(5):355-62. doi: 10.1016/j.annder.2012.03.005. Epub 2012 Apr 21. French.

PMID:
22578339
8.

Review of osteoporosis pharmacotherapy for geriatric patients.

Gates BJ, Sonnett TE, Duvall CA, Dobbins EK.

Am J Geriatr Pharmacother. 2009 Dec;7(6):293-323. doi: 10.1016/j.amjopharm.2009.12.004. Review.

PMID:
20129253
10.

A review of heart failure management in the elderly population.

Cheng JW, Nayar M.

Am J Geriatr Pharmacother. 2009 Oct;7(5):233-49. doi: 10.1016/j.amjopharm.2009.10.001. Review.

PMID:
19948300
11.

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.

Smith CH, Jackson K, Bashir SJ, Perez A, Chew AL, Powell AM, Wain M, Barker JN.

Br J Dermatol. 2006 Jul;155(1):160-9.

PMID:
16792769
12.

Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.

Balasubramaniam P, Stevenson O, Berth-Jones J.

Br J Dermatol. 2004 Apr;150(4):741-6.

PMID:
15099371
13.

Therapy of moderate and severe psoriasis.

Claes C, Kulp W, Greiner W, von der Schulenburg JM, Werfel T.

GMS Health Technol Assess. 2006 Apr 26;2:Doc07.

14.

Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis.

Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U.

Br J Dermatol. 2008 Nov;159(5):1116-23. doi: 10.1111/j.1365-2133.2008.08786.x.

PMID:
18717681
15.

[Opinion of Spanish dermatologists regarding the use of biologic therapy in patients with moderate to severe psoriasis].

Ara M, Pérez A, Ferrando J.

Actas Dermosifiliogr. 2011 Nov;102(9):706-16. doi: 10.1016/j.ad.2011.03.014. Epub 2011 May 19. Spanish.

PMID:
21600532
16.

Efalizumab for the treatment of moderate to severe plaque psoriasis.

Jordan JK.

Ann Pharmacother. 2005 Sep;39(9):1476-82. Epub 2005 Jul 5. Review.

PMID:
15998666
17.

Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.

Verfaille CJ, Thissen CA, Bovenschen HJ, Mertens J, Steijlen PM, van de Kerkhof PC.

J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1038-46.

PMID:
17714122
19.

Cost-effectiveness of moderate-to-severe psoriasis treatment.

Miller DW, Feldman SR.

Expert Opin Pharmacother. 2006 Feb;7(2):157-67. Review.

PMID:
16433581
Items per page

Supplemental Content

Write to the Help Desk